Medicamen Biotech Limited Net Asset Quality Index
Medicamen Biotech Limited net asset quality index. Medicamen Biotech Limited (MEDICAMEQ) has a Net Asset Quality Index of 74.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.72 Billion minus total liabilities of Rs964.38 Million yields net assets of Rs2.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Medicamen Biotech Limited for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Medicamen Biotech Limited (2006–2026)
Net asset quality index of Medicamen Biotech Limited from 2006 to 2026. This chart shows how Medicamen Biotech Limited's Net Asset Quality Index has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the index stands at 74.1%, representing net assets of Rs2.76 Billion against total assets of Rs3.72 Billion INR. Check MEDICAMEQ PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Medicamen Biotech Limited Net Asset Quality Index by Year (2006–2026)
Medicamen Biotech Limited net asset quality index by year from 2006 to 2026. The table below presents the year-by-year Net Asset Quality Index for Medicamen Biotech Limited from 2006 to 2026, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Medicamen Biotech Limited stock valuation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 74.1% | Rs2.76 Billion | Rs3.72 Billion | Rs964.38 Million | ▲ +2.4 pp |
| 2025 | 71.7% | Rs2.13 Billion | Rs2.97 Billion | Rs841.04 Million | ▲ +1.4 pp |
| 2024 | 70.3% | Rs2.07 Billion | Rs2.95 Billion | Rs875.67 Million | ▲ +0.8 pp |
| 2023 | 69.4% | Rs1.93 Billion | Rs2.79 Billion | Rs851.03 Million | ▲ +4.5 pp |
| 2022 | 64.9% | Rs1.46 Billion | Rs2.26 Billion | Rs792.24 Million | ▼ -3.6 pp |
| 2021 | 68.5% | Rs1.33 Billion | Rs1.94 Billion | Rs611.18 Million | ▲ +1.6 pp |
| 2020 | 66.9% | Rs1.21 Billion | Rs1.81 Billion | Rs600.66 Million | ▲ +3.4 pp |
| 2019 | 63.4% | Rs866.34 Million | Rs1.37 Billion | Rs499.59 Million | ▼ 0.0 pp |
| 2018 | 63.5% | Rs746.08 Million | Rs1.18 Billion | Rs429.43 Million | ▲ +27.0 pp |
| 2017 | 36.5% | Rs267.81 Million | Rs734.01 Million | Rs466.20 Million | ▲ +6.6 pp |
| 2016 | 29.8% | Rs179.09 Million | Rs600.18 Million | Rs421.09 Million | ▲ +4.8 pp |
| 2015 | 25.0% | Rs171.85 Million | Rs686.63 Million | Rs514.78 Million | ▼ -0.6 pp |
| 2014 | 25.6% | Rs165.38 Million | Rs645.79 Million | Rs480.41 Million | ▲ +1.5 pp |
| 2013 | 24.1% | Rs157.17 Million | Rs652.34 Million | Rs495.17 Million | ▼ -5.1 pp |
| 2012 | 29.2% | Rs201.01 Million | Rs689.07 Million | Rs488.06 Million | ▲ +0.0 pp |
| 2011 | 29.2% | Rs204.12 Million | Rs700.18 Million | Rs496.06 Million | ▲ +1.0 pp |
| 2010 | 28.2% | Rs162.61 Million | Rs576.83 Million | Rs414.22 Million | ▼ -0.1 pp |
| 2009 | 28.3% | Rs129.60 Million | Rs458.11 Million | Rs328.50 Million | ▲ +5.9 pp |
| 2008 | 22.4% | Rs115.83 Million | Rs517.72 Million | Rs401.88 Million | ▲ +0.7 pp |
| 2007 | 21.7% | Rs100.73 Million | Rs464.17 Million | Rs363.44 Million | ▼ -3.6 pp |
| 2006 | 25.3% | Rs85.67 Million | Rs338.18 Million | Rs252.51 Million | — |